TKFOY yields 1.83% · JNJ yields 2.14%● Live data
📍 TKFOY pulled ahead of the other in Year 1
Combined, TKFOY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TKFOY + JNJ for your $10,000?
Tokyu Fudosan Holdings Corporation, together with its subsidiaries, engages in the real estate business in Japan and internationally. The company operates through four segments: Urban Development, Strategic Investment, Property Management & Operation, and Real Estate Agents. The Urban Development segment develops and operates office buildings, commercial facilities, condominiums, leased housing, and other facilities. The Strategic Investment segment develops and improves infrastructures, such as renewable energy power generation and logistics facilities. The Property Management & Operation segment manages condominiums, buildings and facilities, and other properties; and constructs rental conference rooms and hotels, as well as leisure, healthcare, and environmental and greening management facilities. The Real-Estate Agents segment provides real-estate sales agent service and consignment sales; and engages in operations related to rental housing management. It also owns and manages resort facilities, urban style hotels, senior housings, and membership sports clubs. The company was founded in 1918 and is headquartered in Tokyo, Japan.
Full TKFOY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.